Hans Peter Hammes
Impact in
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research
- Ophthalmology top 2%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
Papers in
-
- Retinal Diseases and Treatments 7
-
- Advanced Glycation End Products research 6
- Co-authors
- Reinhard G. Bretzel (4 shared papers)M. Brownlee (2 shared papers)Jes Thorn Clausen (2 shared papers)Klaus T. Preissner (3 shared papers)Erwin D. Schleicher (1 shared paper)Toshimitsu Niwa (1 shared paper)K. Federlin (2 shared papers)Diane Edelstein (2 shared papers)
- Journals
- Diabetologia (4 papers)The FASEB Journal (2 papers)Experimental and Clinical Endocrinology & Diabetes (2 papers)Investigative Ophthalmology & Visual Science (1 paper)Theranostics (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
Hans Peter Hammes
21 papers receiving 798 citations
Peers
Comparison fields: 5 of 70
- Clinical Biochemistry 335
- Ophthalmology 230
- Endocrinology, Diabetes and Metabolism 180
- Neurology 88
- Biochemistry 42
Countries citing papers authored by Hans Peter Hammes
This map shows the geographic impact of Hans Peter Hammes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Peter Hammes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Peter Hammes more than expected).
Fields of papers citing papers by Hans Peter Hammes
This network shows the impact of papers produced by Hans Peter Hammes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Peter Hammes. The network helps show where Hans Peter Hammes may publish in the future.
Co-authors
The 25 scholars most cited alongside Hans Peter Hammes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 174 | |
| 2 | 1994 | 108 | |
| 3 | N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. | 1999 | 98 |
| 4 | 2003 | 90 | |
| 5 | Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. | 1996 | 88 |
| 6 | 2011 | 42 | |
| 7 | 1996 | 41 | |
| 8 | 1989 | 32 | |
| 9 | 2005 | 32 | |
| 10 | 2017 | 30 | |
| 11 | 2010 | 20 | |
| 12 | 2007 | 19 | |
| 13 | 2010 | 13 | |
| 14 | 2014 | 12 | |
| 15 | 2020 | 10 | |
| 16 | 2014 | 7 | |
| 17 | 1996 | 4 | |
| 18 | 2006 | 4 | |
| 19 | 2009 | 3 | |
| 20 | 2005 | 3 |
About Hans Peter Hammes
Hans Peter Hammes is a scholar working on Ophthalmology, Clinical Biochemistry, Biochemistry, Radiology, Nuclear Medicine and Imaging and Nutrition and Dietetics, having authored 22 papers that have together received 832 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (7 papers), Advanced Glycation End Products research (6 papers), Retinal Imaging and Analysis (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Fatty Acid Research and Health (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Retinopathy of Prematurity Studies (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Clinical Biochemistry (335 citations), Ophthalmology (230 citations), Endocrinology, Diabetes and Metabolism (180 citations), Neurology (88 citations) and Biochemistry (42 citations). Hans Peter Hammes has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Reinhard G. Bretzel, M. Brownlee, Jes Thorn Clausen, Klaus T. Preissner, Erwin D. Schleicher, Toshimitsu Niwa, K. Federlin, Diane Edelstein, S. Martin and Thomas Linn. Their work appears in journals such as Diabetologia, The FASEB Journal, Experimental and Clinical Endocrinology & Diabetes, Investigative Ophthalmology & Visual Science and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.